Free tool
FAERS Monitor: Carbon Dioxide, Usp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 213507 or its brand name (Carbon Dioxide, Usp, Carbon Dioxide). Reports on generic versions are filed under their own applications.
Reports
115
Serious
109
95% of reports
Hospitalization
29
Death reported
14
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- air embolism32
- subcutaneous emphysema20
- off label use16
- post procedural complication9
- cardiac arrest8
- hypotension7
- pneumoperitoneum7
- hypercapnia6
- drug administration error5
- pco2 increased5
- pneumomediastinum5
- intestinal ischaemia4
- pneumonia4
- respiratory acidosis4
- tachycardia4
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 12 |
| 2014 | 11 |
| 2015 | 6 |
| 2016 | 13 |
| 2017 | 5 |
| 2018 | 27 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,044 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| air embolismSignal | 32 | 13345.1 | 9799.1 | 385,639 |
| subcutaneous emphysemaSignal | 20 | 3806.2 | 2542.9 | 70,857 |
| pco2 increasedSignal | 5 | 1294.8 | 547.7 | 5,198 |
| pneumoperitoneumSignal | 7 | 695.7 | 338.9 | 4,171 |
| pneumomediastinumSignal | 5 | 507.4 | 215.0 | 2,041 |
| hypercapniaSignal | 6 | 365.1 | 167.4 | 1,826 |
| respiratory acidosisSignal | 4 | 186.3 | 71.1 | 563 |
| intestinal ischaemiaSignal | 4 | 133.0 | 50.7 | 400 |
| post procedural complicationSignal | 9 | 85.7 | 45.8 | 672 |
| drug administration errorSignal | 5 | 29.8 | 12.6 | 112 |
| cardiac arrestSignal | 8 | 17.7 | 9.1 | 110 |
| tachycardiaSignal | 4 | 8.2 | 3.1 | 19 |
| hypotensionSignal | 7 | 6.4 | 3.1 | 27 |
| off label useSignal | 16 | 3.3 | 2.1 | 25 |
| pneumonia | 4 | 2.3 | 0.9 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.